These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 498172)

  • 21. Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells.
    Foster JL; Conroy PJ; Searle AJ; Willson RL
    Br J Cancer; 1976 May; 33(5):485-90. PubMed ID: 1276030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
    Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Tisman G; Wu SJ
    Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of 5-fluorouracil and natural chemotherapeutic agents, EGCG and thymoquinone, delivered by sustained drug delivery on colon cancer cells.
    Norwood AA; Tucci M; Benghuzzi H
    Biomed Sci Instrum; 2007; 43():272-7. PubMed ID: 17487093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence-dependent activity of 5-fluorouracil plus tauromustine in a transplantable well-differentiated murine colon adenocarcinoma.
    Hill SR; Pollard LA; Bibby MC
    Anticancer Res; 1992; 12(6B):2169-75. PubMed ID: 1295464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Fluorouracil and methotrexate combination chemotherapy: the effect of drug scheduling.
    Mulder JH; Smink T; van Putten LM
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):831-7. PubMed ID: 6949765
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhancement of antitumor effect of cytotoxic agents by bestatin.
    Abe F; Shibuya K; Ashizawa J; Takahashi K; Horinishi H; Matsuda A; Ishizuka M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Mar; 38(3):411-4. PubMed ID: 3924871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of hepatic metastases by long-term chemotherapeutic infusions.
    Pettavel J; Morgenthaler F
    Aktuelle Probl Chir; 1970; 14():865-81. PubMed ID: 4146449
    [No Abstract]   [Full Text] [Related]  

  • 29. Four drug combination cytotoxic chemotherapy following surgery for breast cancer.
    Edelstyn GA; Bates IS; Brinkley D; MacRae KD; Spittle H; Wheeler T
    Recent Results Cancer Res; 1978; 68():109-12. PubMed ID: 752851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of cancers of the colon and rectum].
    Bleiberg H
    Rev Med Brux; 1983 Mar; 4(3):145-6. PubMed ID: 6857050
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies in an animal model on the effectiveness of adjuvant chemotherapy with 5-FU and BCNU in cases of colorectal adenocarcinoma.
    Schmitz R; Hüper J; Pichlmayr R
    J Cancer Res Clin Oncol; 1981; 100(2):213-20. PubMed ID: 7263763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New approaches in administration of anticancer drugs.
    Rall DP
    Cancer Res; 1969 Dec; 29(12):2471-4. PubMed ID: 5369694
    [No Abstract]   [Full Text] [Related]  

  • 33. Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines.
    Benz C; Schoenberg M; Choti M; Cadman E
    J Clin Invest; 1980 Nov; 66(5):1162-5. PubMed ID: 7430346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined chemotherapy of bronchial carcinomas (author's transl)].
    Karrer K; Pridun N; Denck H
    Z Erkr Atmungsorgane; 1980; 155(1):21-40. PubMed ID: 6259843
    [No Abstract]   [Full Text] [Related]  

  • 35. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.
    Teicher BA; Lazo JS; Sartorelli AC
    Cancer Res; 1981 Jan; 41(1):73-81. PubMed ID: 7448778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens.
    Woods RL; Fox RM; Tattersall MH; Levi JA; Brodie GN
    N Engl J Med; 1980 Jul; 303(2):87-9. PubMed ID: 6991941
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combination chemotherapy with orally administered UFT and leucovorin (LV)].
    Okabe H; Saito H; Oie S; Nakano K; Uchida J; Takechi T; Takeda S; Kawaguchi Y; Taguchi T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1645-50. PubMed ID: 1872623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced gastrointestinal malignancy.
    Vaughn CB; Chapman JL; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Brady PR
    Oncology; 1981; 38(3):129-33. PubMed ID: 7010257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of advance colon cancer responding to sequential methotrexate and 5-fluorouracil therapy].
    Iida A; Komatsu T; Ookubo K; Ikeda N
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):661-3. PubMed ID: 8470927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal cancer. Chemotherapy.
    Whitehouse JM
    Recent Results Cancer Res; 1982; 83():126-34. PubMed ID: 7134615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.